The House is unlikely to honor President Donald Trump’s budget request to double user fees, a House GOP aide told Inside Health Policy Wednesday (March 22), emphasizing that key committees have already begun considering the user fee commitments agreed upon between FDA and industry. However, one key Democratic lawmaker was concerned by what they saw as indications that FDA might support reopening the agreements. Lawmakers, FDA officials and industry did not shy away during an Energy & Commerce hearing...